Movement Disorders

A discussion about when a clinician should consider discussing a device-assisted therapy with a patient with advanced Parkinson disease.

Take 5 minutes to catch up on NeurologyLive's highlights from the week ending July 23, 2021.

Basis for the approval was the SENZA-PDN randomized controlled trial, which showed the system’s ability to substantially sustain pain relief and improve health-related quality of life.

Here's what is coming soon to NeurologyLive.

Take 5 minutes to catch up on NeurologyLive's highlights from the week ending July 15, 2021.

Experts discuss their personal experiences using technology and devices in advanced Parkinson disease management and identify patients that are adequately controlled with therapy.

Considerations of gastroparesis in patients with advanced Parkinson disease.

Here's what is coming soon to NeurologyLive.

Neurology News Network for the week ending July 10, 2021.

Take 5 minutes to catch up on NeurologyLive's highlights from the week ending July 9, 2021.

Analyses suggest treatment of Parkinson disease with amantadine (Gocovri; Adamas) may improve freezing and tremor, as well as other M-EDLs.

The effect pridopidine had on reducing mutant HTT-induced endoplasmic reticulum stress via the activation of sigma-1 receptor provided additional evidence of its therapeutic potential.

Experts discuss different strategies to manage concerns relating to advanced Parkinson disease including patient education.

A discussion about how to educate and speak with patients with advanced Parkinson disease.

Here's what is coming soon to NeurologyLive.

Take 5 minutes to catch up on NeurologyLive's highlights from the week ending July 2, 2021.

Patients who received high-dose blarcamesine experienced a 14.51-point MDS-UPDRS total score improvement compared to placebo in a phase 2 study of the Anavex Life Sciences agent.

Michael J. Soileau, MD, discusses how to recognize when a patient has advanced Parkinson disease, what are the initial or relevant signs and symptoms of advanced disease, and how patients shift from early to intermediate and advanced disease.

Joohi Jimenez-Shahed, MD, describes the natural progression of Parkinson disease from the time of diagnosis to advanced disease.

Here's what is coming soon to NeurologyLive.

We kindly ask you to share 5 minutes of your time with us in order to help us better understand how you use social media and how we can better serve you across different platforms.

Take 5 minutes to catch up on NeurologyLive's highlights from the week ending June 25, 2021.

Calli L. Cook, NP, DNP, nurse practitioner, Woodruff School of Nursing, Emory University, detailed her vision for creating change within the neurology field by incorporating advanced practice clinicians.

Aristide Merola, MD, PhD, leads a discussion about the burden and impairment on the quality of life for patients with advanced Parkinson disease.

Experts in the field of Parkinson disease kick off a discussion about recognizing and managing the disease by defining advanced Parkinson disease.

Here's what is coming soon to NeurologyLive.

Take 5 minutes to catch up on NeurologyLive's highlights from the week ending June 18, 2021.

The nurse practitioner at the Woodruff School of Nursing at Emory University detailed why a cultural shift is needed to incorporate APCs into the neurology space and thus improve multidisciplinary care.

Bayer provided an update on their phase 1 and 1b studies of dopaminergic neurons and GDNF gene therapy, respectively, for the treatment of PD.

Despite a few surprising program failures early this year, there is plenty of potential worth holding on to in the Huntington disease pipeline.